Filing Details
- Accession Number:
- 0001181431-14-007430
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-18 18:03:30
- Reporting Period:
- 2014-02-13
- Filing Date:
- 2014-02-18
- Accepted Time:
- 2014-02-18 18:03:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1237401 | C David Hastings | Experimental Station Route 141 &Amp; Henry Clay Road Wilmington DE 19880 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-13 | 7,999 | $8.99 | 16,499 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 9,665 | $11.98 | 26,164 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 13,000 | $14.72 | 39,164 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 16,000 | $18.32 | 55,164 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 90,335 | $11.98 | 145,499 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 66,000 | $17.79 | 211,499 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-13 | 202,999 | $66.12 | 8,500 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-02-14 | 34,964 | $8.99 | 43,464 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-14 | 5,036 | $8.99 | 48,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-14 | 40,000 | $64.74 | 8,500 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-02-18 | 32,001 | $8.99 | 40,501 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-18 | 32,001 | $65.64 | 8,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-13 | 7,999 | $0.00 | 7,999 | $8.99 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-13 | 9,665 | $0.00 | 9,665 | $11.98 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 13,000 | $0.00 | 13,000 | $14.72 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 16,000 | $0.00 | 16,000 | $18.32 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 90,335 | $0.00 | 90,335 | $11.98 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 66,000 | $0.00 | 66,000 | $17.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-14 | 34,964 | $0.00 | 34,964 | $8.99 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-14 | 5,036 | $0.00 | 5,036 | $8.99 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-18 | 32,001 | $0.00 | 32,001 | $8.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,036 | 2015-01-17 | No | 4 | M | Direct | |
| 0 | 2015-02-07 | No | 4 | M | Direct | |
| 79,317 | 2018-01-24 | No | 4 | M | Direct | |
| 28,462 | 2020-02-08 | No | 4 | M | Direct | |
| 0 | 2015-02-07 | No | 4 | M | Direct | |
| 27,900 | 2019-01-18 | No | 4 | M | Direct | |
| 32,001 | 2015-01-17 | No | 4 | M | Direct | |
| 0 | 2015-01-17 | No | 4 | M | Direct | |
| 0 | 2015-01-17 | No | 4 | M | Direct |
Footnotes
- Beginning January 18, 2005, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- Represents weighted average sale price. Actual sales prices ranged from $66.00 - $67.50.
- Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- Beginning February 8, 2008, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Beginning January 25, 2011, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Beginning February 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Represents weighted average sale price. Actual sales prices ranged from $64.00 - $66.46.
- Represents weighted average sale price. Actual sales prices ranged from $65.50 - $65.76.
Billionaire Hedge Funds
